Carpenter Technology Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRS research report →
Range $425 – $620
Price Chart
About the company
Carpenter Technology Corporation is a global leader in the production and supply of high-performance metallic materials, serving markets across the United States, Europe, Asia Pacific, Mexico, and Canada. The company's operations are structured into two primary divisions: Specialty Alloys Operations and Performance Engineered Products. Its diverse product portfolio encompasses advanced alloys like titanium, stainless, alloy, and tool steels, alongside various powder metals, additives, and custom-fabricated metal components.
- CEO
- Brian J. Malloy
- IPO
- 1987
- Employees
- 4,500
- HQ
- Philadelphia, PA, US
Get TickerSpark's AI analysis on CRS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $19.49B
- P/E
- 37.03
- Fwd P/E
- 29.41
- PEG
- 0.90
- P/S
- 6.24
- P/B
- 8.80
- EV/EBITDA
- 23.52
- Div Yield
- 0.20%
- Gross Margin
- 30.58%
- Op Margin
- 22.47%
- Net Margin
- 16.96%
- ROE
- 25.87%
- ROIC
- 17.08%
Latest fiscal year · YoY change
- Revenue
- $3.12B+8.6%
- Gross Profit
- $955.50M+24.3%
- Op Income
- $702.00M
- Net Income
- $529.80M+40.9%
- EPS
- $10.59+41.4%
- OCF Growth
- +37.4%
- FCF Growth
- +26.6%
- 52W High
- $625.99
- 52W Low
- $233.78
- 50D MA
- $474.85
- 200D MA
- $441.77
- Beta
- 1.28
- RSI (14)
- 31
- Avg Volume
- 727.44K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Carpenter Technology reported another record quarter and record fiscal 2026, with strong aerospace demand, expanding margins, robust cash flow, and a bullish outlook for FY2027 and FY2029.· July 30, 2026
- Q4 operating income was a record $206.9 million, up 37% year over year and 11% sequentially.
- SAO margin hit a new record of 37.8%, driving SAO operating income of $229.7 million.
- Sales excluding surcharge rose 9% year over year in Q4 on 22% higher volume; FY2026 adjusted operating income reached $702 million, up 34%.
- The company generated $240.1 million of operating cash flow and $155 million of adjusted free cash flow in Q4; FY2026 adjusted free cash flow was $362.3 million.
- Guidance calls for FY2027 operating income of $850 million to $880 million and FY2029 operating income of about $1.2 billion to $1.3 billion.
In Q4 FY2026, sales excluding surcharge increased 9% year over year on 22% higher volume and 4% sequentially on 11% higher volume. Gross profit was $268.9 million, up 26% from the same quarter last year and up 7% sequentially. Operating income was a record $206.9 million, up 37% year over year and 11% sequentially, and EPS was $3.23; the effective tax rate was 20.7%. SAO net sales excluding surcharge were $607.4 million, up 11% year over year and 4% sequentially, with a record 37.8% adjusted operating margin and $229.7 million of operating income. PEP net sales excluding surcharge were $98.2 million, up 1% year over year and 8% sequentially, with operating income of $7.1 million. For FY2026, adjusted operating income was $702 million, up 34% year over year, and adjusted free cash flow was $362.3 million. For FY2027, management guided to total operating income of $850 million to $880 million, including SAO of $218 million to $222 million, PEP of $6 million to $7 million, and corporate costs of about $29 million; adjusted free cash flow is expected to be $400 million to $430 million. Management also reiterated FY2029 operating income of approximately $1.2 billion to $1.3 billion, and said the brownfield project remains on budget and on schedule to be completed by the start of FY2028.
Tony Thene emphasized that the company is operating in an accelerating demand environment, led by aerospace and defense, where Boeing and Airbus build-rate increases should support further growth. He repeatedly framed FY2027 guidance as conservative and said he would view it as a floor, not a ceiling, while stressing the company sets targets it can confidently achieve and then works to exceed them. He also highlighted the long-term runway from productivity, mix, pricing, and the brownfield expansion, and said FY2029 is not expected to be the peak of earnings power.
Tim Lain focused on the financial leverage in the quarter: sales excluding surcharge were up 9% year over year, gross profit rose to $268.9 million, operating income reached $206.9 million, and EPS was $3.23. He said FY2026 cash from operations was $605 million, up 37%, and adjusted free cash flow was $362.3 million, supported by disciplined working capital management; liquidity stood at $892.4 million, including $393.3 million of cash and $499.1 million of available borrowings, with net debt-to-EBITDA well below 1x. On capital allocation, he noted $179.1 million of buybacks in FY2026, $281 million spent to date under the $400 million authorization, $242.7 million of capex in FY2026, and $85.1 million of Q4 capex as the brownfield project ramped.
Analysts pressed management on why FY2027 guidance implies some moderation in EBIT growth, and Tony responded that he does not necessarily disagree and would treat the guide as a floor. Questions also focused on the brownfield project, where Tim said the project is on schedule, on budget, and expected to be OI-accretive in FY2028, with the prior $150 million incremental OI target for 2030 still held out, though they are more confident it could be higher. Management was also asked about cautious structural customers, and Tony said they are holding back mainly because they have been burned before, but he expects a significant pickup as Boeing continues to improve. On LTAs, Tony said a couple of significant contracts will renew over the next two years, including one currently being worked on, and confirmed there are still a small number of pre-COVID agreements left.
The bull case from this call is that Carpenter is still seeing demand accelerate across its highest-value end markets, especially aerospace, where customers are asking for more material and build rates are rising. The company is pairing that demand with record margins, strong free cash flow, a well-funded buyback/dividend program, and a brownfield project that management says could add meaningful earnings starting in FY2028.
The main risks discussed were that some structural aerospace customers are still ordering cautiously and that near-term growth could depend heavily on how quickly Boeing and Airbus ramp. Management also acknowledged that the brownfield earnings contribution is hard to model precisely because of product mix uncertainty, and that FY2027 guidance is intentionally set with caution, implying some moderation from the recent pace of earnings acceleration.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 96.7%
- Shares Outstanding
- 49.69M
- Float Shares
- 48.07M
of shares held by institutions
910 13F filers
Buy/sell ratio 0.47. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for CRS, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 6.22M | ▲ 394.37K |
| Vanguard Group Inc | 4.51M | ▼ 42.32K |
| Fmr LLC | 4.18M | ▼ 141.41K |
| Vanguard Capital Management LLC | 2.16M | ▲ 7.15K |
| Vanguard Portfolio Management LLC | 2.11M | ▲ 57.26K |
| State Street Corp | 1.91M | ▼ 101.64K |
| Invesco Ltd. | 1.58M | ▼ 396.00K |
| Aqr Capital Management LLC | 1.46M | ▲ 735.01K |
| Jennison Associates LLC | 1.19M | ▲ 387.38K |
| Jpmorgan Chase & Co | 1.18M | ▲ 779.01K |
| Geode Capital Management, LLC | 1.01M | ▼ 86.79K |
| Lone Pine Capital LLC | 962.84K | ▼ 855.10K |
Held by 966 ETFs
Biggest fund positions in CRS by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 30, 26 | MCLANE CHARLES DOUGLAS JR | other | 69.12 |
| Sep 30, 26 | BECK JULIE A | other | 53.05 |
| Sep 4, 26 | KAROL STEVEN E | other | 3,275 |
| Sep 4, 26 | KAROL STEVEN E | sell | 3,275 |
| Sep 4, 26 | KAROL STEVEN E | other | 3,275 |
| Aug 25, 26 | Thene Tony R | sell | 2,095 |
| Aug 25, 26 | Thene Tony R | sell | 2,370 |
| Aug 25, 26 | Thene Tony R | sell | 1,995 |
| Aug 25, 26 | Thene Tony R | sell | 10,004 |
| Aug 25, 26 | Thene Tony R | sell | 11,899 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CRS coverage
Recent articles, reports, and earnings notes.
Want a deeper read on CRS?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
6,806 Carpenter Technology Corporation $CRS Shares Sold by Tompkins Financial Corp
defenseworld.net · Oct 6
Poolbeg secures South Korean cancer immunotherapy-induced CRS patent
proactiveinvestors.com · Oct 6
Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell
gurufocus.com · Oct 5
AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates Significant Improvement in Progression-Free Survival versus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell
gurufocus.com · Oct 5
Carpenter Technology Announces Conference Call and Webcast
globenewswire.com · Oct 1
Carpenter Technology (CRS) is a Top-Ranked Growth Stock: Should You Buy?
zacks.com · Sep 21
Our Top 10 High Growth Dividend Stocks - September 2026
seekingalpha.com · Sep 19
After Plunging 18.6% in 4 Weeks, Here's Why the Trend Might Reverse for Carpenter (CRS)
zacks.com · Sep 14
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
